Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam benzenesulfonate versus propofol for emergence agitation and postoperative delirium after general anesthesia
ChiCTR2200058385Phase 4Recruiting
- Sponsor
- Ningxia Hui Autonomous Region People's Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in None (2 arms), sponsored by Ningxia Hui Autonomous Region People's Hospital. Primary endpoints: Agitation during awakening, Postoperative delirium and 10 more. Started Dec 2020; status: recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2200058385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058385.